<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Krissberg JR</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>105-117</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8553235</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1(3)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Disparities in health-related quality of life (HRQOL) have been inadequately studied in patients with glomerular disease. The aim of this study was to identify relationships between race/ethnicity, socioeconomic status, disease severity, and HRQOL in an ethnically and racially diverse cohort of patients with glomerular disease.&lt;h4>Methods&lt;/h4>Cure Glomerulonephropathy (CureGN) is a multinational cohort study of patients with biopsy-proven glomerular disease. Associations between race/ethnicity and HRQOL were determined by the following: 1. Missed school or work due to kidney disease; 2. Responses to Patient Reported Outcomes Measurement Information System (PROMIS) questionnaires. We adjusted for demographics, socioeconomic status, and disease characteristics using mult</pubmed_abstract><journal>Glomerular diseases</journal><pubmed_title>Racial-ethnic differences in health-related quality of life among adults and children with glomerular disease.</pubmed_title><pmcid>PMC8553235</pmcid><funding_grant_id>U01 DK100876</funding_grant_id><funding_grant_id>U24 DK100845</funding_grant_id><funding_grant_id>UM1 DK100845</funding_grant_id><funding_grant_id>UM1 DK100867</funding_grant_id><funding_grant_id>UM1 DK100846</funding_grant_id><funding_grant_id>UM1 DK100876</funding_grant_id><funding_grant_id>TL1 TR001875</funding_grant_id><funding_grant_id>UM1 DK100866</funding_grant_id><funding_grant_id>U01 DK100867</funding_grant_id><funding_grant_id>U01 DK100866</funding_grant_id><funding_grant_id>U01 DK100846</funding_grant_id><pubmed_authors>Wenderfer SE</pubmed_authors><pubmed_authors>Twombley K</pubmed_authors><pubmed_authors>Vasylyeva TL</pubmed_authors><pubmed_authors>Parekh RS</pubmed_authors><pubmed_authors>Gbadegesin RA</pubmed_authors><pubmed_authors>Gibson KL</pubmed_authors><pubmed_authors>Chatterjee D</pubmed_authors><pubmed_authors>Reidy KJ</pubmed_authors><pubmed_authors>Krissberg JR</pubmed_authors><pubmed_authors>Khalid M</pubmed_authors><pubmed_authors>David T Selewski</pubmed_authors><pubmed_authors>Weaver DJ</pubmed_authors><pubmed_authors>O'Shaughnessy MM</pubmed_authors><pubmed_authors>Almaani S</pubmed_authors><pubmed_authors>Lafayette R</pubmed_authors><pubmed_authors>Jain K</pubmed_authors><pubmed_authors>Helmuth ME</pubmed_authors><pubmed_authors>Kidd JM</pubmed_authors><pubmed_authors>Kopp JB</pubmed_authors><pubmed_authors>Tuttle KR</pubmed_authors><pubmed_authors>Cattran D</pubmed_authors><pubmed_authors>John Sperati C</pubmed_authors><pubmed_authors>Glenn DA</pubmed_authors><pubmed_authors>Iragorri S</pubmed_authors><pubmed_authors>Cai Y</pubmed_authors><pubmed_authors>Greenbaum LA</pubmed_authors><pubmed_authors>Nestor JG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Racial-ethnic differences in health-related quality of life among adults and children with glomerular disease.</name><description>&lt;h4>Introduction&lt;/h4>Disparities in health-related quality of life (HRQOL) have been inadequately studied in patients with glomerular disease. The aim of this study was to identify relationships between race/ethnicity, socioeconomic status, disease severity, and HRQOL in an ethnically and racially diverse cohort of patients with glomerular disease.&lt;h4>Methods&lt;/h4>Cure Glomerulonephropathy (CureGN) is a multinational cohort study of patients with biopsy-proven glomerular disease. Associations between race/ethnicity and HRQOL were determined by the following: 1. Missed school or work due to kidney disease; 2. Responses to Patient Reported Outcomes Measurement Information System (PROMIS) questionnaires. We adjusted for demographics, socioeconomic status, and disease characteristics using mult</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-26T13:21:11.577Z</modification><creation>2025-04-06T14:13:33.099Z</creation></dates><accession>S-EPMC8553235</accession><cross_references><pubmed>34723246</pubmed><doi>10.1159/000516832</doi></cross_references></HashMap>